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ABSTRACT
The 3D-printed boluses were used during the radiation therapy of the chest 
wall in six patients with breast cancer after modified radical mastectomy (MRM). We 
measured the in-vivo skin doses while both conventional and 3D-printed boluses were 
placed on the chest wall and compared the mean doses delivered to the ipsilateral 
lung and the heart. The homogeneity and conformity of the dose distribution in the 
chest wall for both types of boluses were also evaluated. The uniformity index on the 
chest skin was improved when the 3D-printed boluses were used, with the overall 
average skin dose being closer to the prescribed one in the former case (-0.47% 
versus -4.43%). On comparing the dose-volume histogram (DVH), it was found that 
the 3D-printed boluses resulted in a reduction in the mean dose to the ipsilateral 
lung by up to 20%. The precision of dose delivery was improved by 3% with the 
3D-printed boluses; in contrast, the conventional step bolus resulted in a precision 
level of 5%. In conclusion, the use of the 3D-printed boluses resulted in better dose 
homogeneity and conformity to the chest wall as well as the sparing of the normal 
organs, especially the lung. This suggested that their routine use on the chest wall as 
a therapeutic approach during post-mastectomy radiation therapy offers numerous 
advantages over conventional step boluses.
INTRODUCTION
Electron conformal therapy has been used for 
treating superficial cancers and diseases for a long time, 
owing to the fact that it results in specific dose distribution. 
The electron beam delivers a uniform dose of radiation to 
the planning target volume (PTV) and has a sharp distal 
fall off. Furthermore, it reduces unnecessary irradiation 
to the underlying healthy normal tissue. However, 
inhomogeneous dose delivery in the target volume owing 
to irregularities in the skin surface and varying target 
depths can occur [1]. To compensate for the missing 
tissue, to ensure that the dose distribution conforms 
to the target volume, and to make the thickness of the 
chest wall uniform with a compensator, discontinuously 
step-structured boluses of various thicknesses have been 
employed. However, step boluses result in hot and cold 
spots in the dose distribution. To remedy this problem, 
boluses having continuously smooth surfaces and made of 
rubber [2] and wax and fabricated using computer-driven 
milling machines have been investigated [3, 4]. These 
efforts have successfully improved the conformity of the 
dose distribution by using appropriate dose calculation 
algorithms and customized boluses and have been 
extended to the treatment of head and neck tumors [5]. 
Furthermore, the technique of intensity modulation using 
wax boluses produced by computer-driven machines has 
also been introduced [6]. 
Recently, given the widespread availability of three-
dimensional (3D) printers, Burleson et al. [7] have reported 
the benefits of such printers, which are lower operational 
and production costs. Moreover, Zou et al. [8] reported 
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that 3D printers have the ability to fabricate compensators 
with much finer patterns. As this trends, Park et al. [9] 
used the 3D-printed bolus for Kimura’s disease as a case 
report. However, the clinical and routinized application 
of boluses and compensators fabricated using 3D printers 
has not yet been attempted for the breast cancer patients. 
In this study, we employed 3D-printed boluses during the 
electron radiation therapy of the chest wall for six patients 
with breast cancer who had undergone mastectomy and 
compared the dose homogeneity, conformity, and normal 
organ sparing effects of the 3D-printed boluses with those 
of conventional step boluses.
RESULTS
Results of in-vivo measurements
Figure 1 (a) shows the averages of the five skin 
doses for the six patients corresponding to the use of the 
conventional step bolus and the 3D-printed bolus. The 
overall average in the case of the 3D-printed boluses 
was closer to the prescribed dose (--0.47% percentage 
difference), while for the conventional step bolus, the 
overall average value was -4.43%. The standard deviations 
(STD) for the values measured at the five points were also 
shown as error bars; the STDs corresponding to the use of 
the 3D-printed boluses were much smaller than those to 
the use of the conventional step bolus. This showed that 
the uniformity of the dose distribution on the chest skin 
improved with the use of the 3D-printed boluses. 
When the central doses were measured along 
the beam axis, the percentage differences compared 
to prescribed dose were 3% and 6% in the case of the 
3D-printed boluses and the conventional step bolus, 
respectively (Figure 1 (b)).
Results of plan comparison
The DVH curves for all the patients are shown 
in Figure 2. The use of the 3D-printed boluses reduced 
the dose absorbed by the normal organs in most of the 
cases. The mean doses delivered to the ipsilateral lung 
and the heart, which are listed in Table 1, highlight the 
effectiveness of the 3D-printed boluses. The table also 
shows the standard deviations in the doses delivered to 
the chest wall, indicating the homogeneity of the dose 
distribution. In the case of patient 4, the mean dose to 
the heart increased with the use of the 3D-printed bolus, 
because the thickness of the 3D-printed bolus above the 
heart was lower than that of the conventional step bolus 
(the thickness of the 3D-printed bolus in this area was 2 
mm while that of the conventional step bolus was 5 mm). 
However, the mean dose to the ipsilateral lung decreased 
when we used the 3D-printed boluses in all the patients. In 
patient 5, the mean dose to the ipsilateral lung was reduced 
by up to 20%. The homogeneity, described in terms of 
the standard deviation in the dose to the chest wall, also 
improved for most patients. The exception was patient 5; 
the homogeneity increased to 3.3%, which corresponded 
to a dose 0.1 Gy. For the conformity index (CI), all the 
patients exhibited improved results. For instance, the CI 
Table 1: The change in dosimetric parameters derived from DVH curve
Gy Dmean(CW)
Dmean(Lung)
Dmean(Heart)
Conformity Index
(Coverage of 90% 
isdose to CW)
Homogeneity Dstd(CW)
Bolus 
type
Both 
(normalized)
Conv. 
step 3D printed
Conv. 
step 3D printed
Conv. 
step 3D printed
Conv. 
step 3D printed
Patient 
1 48.13 7.00 6.88 (-1.7%) 5.24 5.19(-1.0%) 0.65 0.70 (7.9%) 2.98
2.93 
(-1.7%)
Patient 
2 48.62 10.28
9.22 
(-10.3%) 2.38 2.22(-6.8%) 0.86 0.86 (0.5%) 2.38
2.35 
(-1.4%)
Patient 
3 49.60 5.19          5.17 (-0.3%) 4.40 4.30(-2.2%) 0.78 0.92 (18.4%) 3.06
2.79 
(-8.8%)
Patient 
4 46.33 8.09 7.96 (-1.5%) 1.66 1.71(3.2%) 0.90 0.93 (2.7%) 2.43
2.30 
(-5.3%)
Patient 
5 48.00 10.02 8.02 (-20%) 5.44 4.65(-14%) 0.65 0.71 (9.5%) 2.53 2.62 (3.3%)
Patient 
6 50.31 14.13 12.17 (-14%) 5.67 4.73(-17%) 0.53 0.76 (45.0%) 2.29 2.04 (-11%)
Mean 48.50 9.15 8.24 4.13 3.80 0.72 0.81 2.61 2.51
Median 48.38 9.06 7.99 4.82 4.48 0.72 0.81 2.48 2.49
All parameters are normalized based on the condition of the same mean dose on chest wall.
All unit is Gy except for unitless conformity index.
The number in parenthesis is percentage difference compared to conventional step bolus
Conv. and CW stand for “conventional” and “chest wall” respectively.
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value of patient 6 improved to 45%, in contrast to the case 
when the conventional step bolus was used. In Figure 3, 
dose distributions of the cases for the use of 3D printed 
and conventional step boluses were showed respectively. 
In the case for the use of conventional step bolus, 
discontinuous shape of bolus showed several relatively 
hot and cold spots, while continuous and uniform depth 
of chest wall plus 3D-printed bolus reduced the hot and 
cold spots, which resulted in improving dose conformity 
and uniformity.
DISCUSSION
In this study, we used individually customized 
boluses, which were designed to compensate for the 
differences in the chest wall thickness and to reduce the 
irradiation dose delivered to the lungs and the heart during 
the irradiation of the chest wall of post-mastectomy breast 
cancer patients. While using the individually customized 
boluses with the reverse hockey stick method, the normal 
tissue complication probability of the ipsilateral lung was 
Figure 1:  (a) Results of the in-vivo measurements of five skin doses for the six patients. Based on the values of the STD (error 
bars), it was concluded that the uniformity of the dose distribution on the chest skin improved with the use of the 3D-printed boluses. 
Further, the overall average value was closer to the prescribed dose in the case of the 3D-printed boluses. (b) Doses measured along the 
central axis. When the 3D-printed boluses were used, the precision improved to 3%; in contrast, that in the case of the conventional step 
bolus was 5%. A word “pt” stands for patient.
Oncotarget25663www.impactjournals.com/oncotarget
reduced by approximately 24.5–40.5%; this was in line 
with the decrease in the rate of radiation pneumonitis 
development [10].
The use of the 3D-printed boluses can be compared 
to the use of boluses fabricated from resin-impregnated 
wax using a computer-driven milling machine [3]. Thus, 
it was worthwhile to compare the two bolus types. 
According to Low et al. [3], the manufacturing precision 
of conventional boluses is determined by the tool path 
spacing and the diameter of the ball-end mill bit, which 
were 2 mm and 4 mm, respectively. On the other hand, 
the precision of the 3D printing system used in this study 
was determined by both the printing layer thickness and 
the nozzle diameter, which were 0.5 mm and 0.4 mm, 
respectively. Therefore, the manufacturing precision of 
the 3D-printed boluses was higher, thereby resulting in 
more precise dose delivery. The physical densities of wax 
and polyactic acid (PLA, material used in 3D-printing) are 
0.92 and 1.19, respectively, which are close to that of soft 
tissue. However, acrylonitrile butadiene styrene (ABS) is 
used preferentially as a tissue-equivalent material. Thus, 
it is necessary to improve the properties of ABS so that 
Figure 2: DVH curves for the six patients. The inset plots are the log-scale DVH curves highlighting the differences between the 
two types of boluses for smaller differences in the percentage volume values. The use of the 3D-printed boluses resulted in lower doses to 
the normal organs (lungs and heart).
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it can be used with 3D printing. This would entail fixing 
issues such as the bending and warping of ABS during 3D 
printing. 
The results of this study confirmed that the 
dosimetric parameters improved with the use of the 
3D-printed boluses instead of the conventional step bolus. 
This included improvements in the precision of the central 
dose, dose homogeneity, and the CI value. However, in 
some cases (e.g., patient 4), the mean dose to the heart 
was lower in the case of the conventional step bolus, 
because the minimum thickness of the conventional step 
bolus was 5 mm, while it was 2 mm in the case of the 
3D-printed bolus. In order to overcome problems such as 
that encountered in the case of patient 4, the design of the 
3D-printed boluses should be modified using a computer 
algorithm. For example, a thickness constraint could 
be applied to reduce the dose absorbed by the normal 
organs. The computer-aided design of 3D-printed boluses 
could allow for more precise shape control and improve 
the dosimetric parameters. As suggested by Su [11], the 
computer-aided design process could be expanded to the 
bolus-based modulation of electron radiation therapy 
(MERT). The anatomic inhomogeneities encountered 
hinder precise dose delivery, an important factor to 
consider in the development of the algorithms for MERT. 
The technique used in this study could easily be 
extended to the treatment of other superficial lesions. 
A 3D image of the area to be treated can be acquired 
from imaging sources such as MRI, CT, and optical 3D 
imaging scans for both electron and photon beam therapy. 
Even though the development of materials that can be 
considered tissue equivalent as well as reductions in the 
printing time are still necessary, the dosimetric results 
obtained in this study confirmed that the technique is 
suitable for clinical use.
In conclusion, the main purpose of this study was 
to confirm whether 3D-printed boluses are better suited 
instead of conventional step boluses for use during electron 
conformal therapy. Based on in-vivo measurements, it was 
found that the 3D-printed boluses improved the precision 
of the dose absorbed by the chest wall to 3%; in contrast, 
the use of the conventional step bolus resulted in a dose 
uncertainty of up to 6%. Furthermore, the homogeneity 
of the dose distribution both on the surface and within the 
chest wall was improved. In addition, the dose absorbed 
by the normal organs was reduced by up to 20%. From 
these results, it can be concluded that there are a number 
of advantages of employing 3D-printed boluses for routine 
electron conformal therapy following MRM. Lastly, we 
have provided the details of the procedure for designing 
Table 2: Patient characteristics
Patient Age pathology T stage N stage Tumor size(diameter) Site
Pt 1 52 IDC 3 3 5.5cm LUO (Left)
Pt 2 54 IDC 2 2 2.5cm RUC (Right)
Pt 3 65 IDC 2 2 2.5cm LOC (Left)
Pt 4 57 ILC 3 2 6.0cm ROC (Right)
Pt 5 58 IDC 4 2 7.0cm All quadrant (Left)
Pt 6 59 IDC 2 2 3.9cm LUO (Left)
Figure 3: Example of dose distributions. (a) The use of 3D printed bolus. (b) The use of conventional step bolus. In conventional 
step bolus, discontinuous shape of bolus showed several relatively hot and cold spots, while continuous and uniform depth of chest wall 
plus bolus reduced the hot and cold spots resulting in improving dose conformity and uniformity.
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Figure 5: (a) The conventional step bolus and (b) a 3D-printed bolus. The conventional step bolus was made of two 5-mm-thick 
Superflab® boluses. And examples of in-vivo measurements: (c) the five measurement points on a patient’s chest and (d) the placement of 
a 3D-printed bolus on patient 6
Figure 4:  Schematic description of the procedures involves, which ranged from CT image acquisition to the placement 
of the 3D-printed bolus on the patient.
Oncotarget25666www.impactjournals.com/oncotarget
and creating 3D-printed boluses in detail for other users 
without having to take the trial-and-error approach.
MATERIALS AND METHODS
1. Fabrication of 3D-printed customized boluses
Several studies have confirmed the advantages of 
electron conformal therapy performed using customized 
3D-printed electron boluses and compensators over that 
performed with conventional ones [7, 8, 11, 12]. However, 
since these studies used the 3D-printed boluses only on 
phantoms and did not provide details of the procedures 
used, there remained a lack of information regarding their 
use with actual patients. Thus, in this paper, we describe 
the procedures used in detail so that they can be used by 
other users as well, eliminating the need for a trial-and-
error approach. The five steps involved are outlined in 
Figure 4 and are described below.
Step 1: Acquiring source image
The image data for each patient as the DICOM (the 
digital imaging and communications in medicine) file 
format was acquired during computed tomography (CT) 
simulation. A CT slice was collected every 3 mm and 
reconstructed as a 1-mm-spaced slice. This source image 
was modified as required. As an example, to ensure clean 
and sharp images of the inner surface of the chest wall, 
it was sometimes necessary to erase the adjacent organs, 
such as the heart, from the collected images. In addition, 
to allow for precise placement of the bolus on the patient’s 
chest, position markers were added to the images. The 
modifications to the CT images were performed using the 
MIM Maestro software (version 6.1, MIM Software Inc., 
USA). 
Step 2: Converting source images into 3D object 
The acquired source images were used to create 
virtual 3D-printable boluses. This was done using two 
applications: 3D Slicer (www.slicer.org) and Blender 
(www.blender.org). These applications are open source 
and free to use in any institution or clinic. The 3D Slicer 
was used to convert the patient’s CT data into the data 
(in the stereolithography (STL) file format) that could be 
read by 3D printer applications and to define the region 
to be used to form the bolus. An initial 3D bolus object 
was created in 3D Slicer having the surface information 
in terms of triangular meshes, the number of which 
determines the file size as well as the smoothness of the 
object surface.
Step3: Designing virtual 3D bolus
The initial 3D virtual object defined in the STL 
file was imported into Blender, in order to be able to 
control the mesh and modify the shape of the bolus. The 
converted raw 3D object from 3D Slicer was refined by 
eliminating any defective meshes. Since there were a 
number of meshes, it was not possible to find and remove 
the defected ones manually. Thus, the cleaning and fixing 
of the meshes was done by forming a new surface; this, 
in turn, was accomplished by creating a sphere and using 
it as a new surface. The initial 3D object was wrapped 
within the sphere using the built-in “shrink-wrap” function 
in Blender. This new surface, which was identical to the 
surface of the initial 3D object, replaced the original 
surface. 
The shape of a 3D-printable bolus should be such 
that it has the same contours as the lung-sided and skin-
sided chest walls of the patient. The upper surface of the 
3D-printable bolus should conform to the lung-sided 
surface of the chest wall, while the lower surface should 
conform to the skin-sided surface to compensate missing 
tissue for the uniform thickness of chest wall as shown in 
Figure 4. To design the 3D virtual boluses, two objects 
(A and B in Figure 4) were extracted from the raw 3D 
object; these conformed to the chest skin (body-shaped 
object, A in Figure 4) and lung-sided surface of the chest 
wall (lung-shaped object, B in Figure 4), respectively. The 
final bolus was obtained from the difference in these two 
objects. In other words, the upper surface of 3D-printed 
bolus extracted from the lung shaped object (B in Figure 
4), and the lower surface from the chest skin (A in Figure 
4).
Step 4: Printing actual 3D bolus
After the completion of the bolus design process, 
the boluses were fabricated with a 3D printer using PLA 
filament, whose physical density (p) was 1.19 kg/m3 and 
different from that of human tissue. We did not use ABS 
as the fabrication material even though it has a density 
similar to that of tissue, because ABS filaments more than 
5cm in size tended to bend during the cooling process. 
To calculate the dose in TPS, the 3D-printed bolus in the 
CT scan was overrided as the density of 1.19. We used 
a CubeX® (3D systems, USA) as the printing hardware 
and KISSlicer (www.kisslicer.com) as the software; this 
software is available under an open-source license. The 
boluses were printed used the following parameters; speed 
of 30 mm/s, layer thickness of 0.5 mm, and infill ratio of 
100%. The other parameters in KISSlicer were determined 
after careful calibration; for this purpose, we repeatedly 
printed cubes with a volume of 3 cm3. These printing 
parameters were chosen to reduce the time to print. The 
average printing time for the six 3D-printed boluses was 
less than 6 hours.
Step 5: Placing bolus on patient
To place the 3D-printed boluses on the patients with 
precision, cone-beam CT (CBCT) images were acquired, 
in order to align the position of the bolus by comparing it 
with the planned CT image. Further, a gel (Progel®;  p = 
1.02 kg/m3) that is used for acquiring ultrasonic images 
Oncotarget25667www.impactjournals.com/oncotarget
was employed for eliminating any possible air gaps 
between the patient skin and the bolus. The alignment of 
the 3D-printed boluses using CBCT was performed only 
during the first treatment fraction.
2. Clinical applications and in-vivo measurements
Patient characteristics and prescribed dose
The 3D-printed boluses were used with six patients, 
as shown in Table 2, who had been prescribed radiation 
therapy following MRM. Radiation was given once per 
day at doses of 1.8Gy per fraction (28 fractions, 50.4Gy) 
on the skin along the central axis. The treatment plan was 
implemented using the reverse hockey stick technique 
[13] and performed by the treatment planning system 
(TPS), RayStation (RaySearch Laboratories, USA) based 
on CT scan acquired from the CT simulator, Somatom 
(Siemens, Germany). The delineation of PTV and normal 
structures followed RTOG and ESTRO guidelines [14]. 
All patients were treated by the machine, Elekta Versa HD 
which has electron modalities of 6, 9, 12, and 15MeV. This 
Institutional Review Board of the Gangnam Severance 
Hospital, Korea (IRB No. 3-2015-0325) approved this 
retrospective study in accordance with ethical guidelines 
and the Declaration of Helsinki.
In-Vivo measurements of skin dose
For the measurements of skin dose, Gafchromic 
films, EBT3 (Radiation Products Design, Inc., USA) were 
used to verify whether the dose absorbed by the chest skin 
was in keeping with the desired value. The measurements 
were performed using the two kinds of boluses, as shown 
in Figure 5 (a) and (b): a conventional step bolus at the 
first fraction and a 3D-printed one for the other fractions. 
A dosimetric comparison of the two types of boluses 
helped validate the applicability of the 3D-printed boluses. 
The measurements were made at five points, including at 
the position of the central axis, as shown in Figure 5 (c). 
Plan comparison
In addition to the in-vivo measurements, the two 
plans used with the conventional step bolus and the 
3D-printed bolus were compared. The two plans had the 
same dose prescribed and were normalized to have the 
same mean dose of the chest wall, in order to simulate two 
independent plans. We calculated the mean doses for both 
the ipsilateral lung and the heart from the normalized DVH 
curves and compared the homogeneities of the calculated 
doses for the chest wall on being irradiated by the electron 
beam; these were also determined from the DVH curves 
[15]. The differential DVH curve can be obtained from the 
derivative of the cumulative DVH. If the differential DVH 
is expressed as a function of the dose, v(D), the mean dose, 
Dmean, and the standard deviation in the dose in the region 
of interest, then, Dstd, can be evaluated as follows:
max
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0
mean
0
( )
( )
D
D
D v D dD
D
v D dD
⋅
= ∫
∫
( )max
max
2
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0
( )
( )
D
D
D D v D dD
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∫
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The conformity index (CI) is also an important 
dosimetric parameter and gives an idea of how well the 
PTV is covered by the radiation field. We calculated the CI 
value using the method suggested by Lomax and Scheib 
[16].
RI
RI
TV
CI=
V
(2)
where VRI is the volume of the reference isodose 
(90%), and TVRI is the target volume covered by the 
reference isodose.
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